While OPN has been studied in the general population as a biomarker for a variety of diseases, including cancer, autoimmune disorders [18], vascular calcification, and atherosclerosis [19], its role in cardiovascular disease in hemodialysis patients remains an emerging area of research [19]. This evidence concerns the gene SPP1 and cardiovascular disorder.